A series of settlement conferences will be held with drug makers in September and October 2022, weeks before the first Nexium lawsuit is set to go before a jury involving kidney disease caused by the heartburn drug
Lawsuit over chronic kidney disease from Nexium will be the first of more than 13,500 claims to go before a jury when trial begins in November 2022
First case to go to trial involves a Nexium lawsuit filed over a kidney disease diagnosis, which is expected to be followed by additional bellwether trials in March 2023 and April 2023
Large groups of Nexium lawsuits, Prilosec lawsuits and other claims involving kidney damage following use of popular heartburn drugs will be selected each quarter, and prepared for trial
After first round of bellwether trials begin in October 2022, a second round of kidney damage lawsuits will be prepared to go before juries by late next year.
The first Nexium bellwether lawsuit is scheduled to go before a jury in October
More than 13,000 Nexium lawsuits, Prilosec lawsuits, Protonix lawsuits and other complaints involving kidney side effects from proton pump inhibitor (PPI) heartburn drugs are pending throughout the federal court system.
